Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer and Other Cancer Treatment. The most proportion of Oncology Drugs used for Blood Cancer and the proportion in 2019 is 22%. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Oncology/Cancer Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Oncology/Cancer Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Oncology/Cancer Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi
Eli Lilly and Company
HENGRUI
GuiZhou YiBai
LUYE
HANSOH
Roche
AstraZeneca
Novartis
QILU
Lunan
By Type:
Antimetabolite
Alkaloid Drugs
Hormone
Targeted Drug
Platinum-based Drugs
Other
By End-User:
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology/Cancer Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Oncology/Cancer Drugs Market Size and Growth Rate of Antimetabolite from 2016 to 2027
-
1.3.2 USA Oncology/Cancer Drugs Market Size and Growth Rate of Alkaloid Drugs from 2016 to 2027
-
1.3.3 USA Oncology/Cancer Drugs Market Size and Growth Rate of Hormone from 2016 to 2027
-
1.3.4 USA Oncology/Cancer Drugs Market Size and Growth Rate of Targeted Drug from 2016 to 2027
-
1.3.5 USA Oncology/Cancer Drugs Market Size and Growth Rate of Platinum-based Drugs from 2016 to 2027
-
1.3.6 USA Oncology/Cancer Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Oncology/Cancer Drugs Market Size and Growth Rate of Blood Cancer from 2016 to 2027
-
1.4.2 USA Oncology/Cancer Drugs Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
1.4.3 USA Oncology/Cancer Drugs Market Size and Growth Rate of Gastrointestinal Cancer from 2016 to 2027
-
1.4.4 USA Oncology/Cancer Drugs Market Size and Growth Rate of Prostate Cancer from 2016 to 2027
-
1.4.5 USA Oncology/Cancer Drugs Market Size and Growth Rate of Respiratory/Lung Cancer from 2016 to 2027
-
1.4.6 USA Oncology/Cancer Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Oncology/Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Oncology/Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Oncology/Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Oncology/Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Oncology/Cancer Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Oncology/Cancer Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Antimetabolite
-
3.4.2 Market Size and Growth Rate of Alkaloid Drugs
-
3.4.3 Market Size and Growth Rate of Hormone
-
3.4.4 Market Size and Growth Rate of Targeted Drug
-
3.4.5 Market Size and Growth Rate of Platinum-based Drugs
-
3.4.6 Market Size and Growth Rate of Other
4 Segmentation of Oncology/Cancer Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Oncology/Cancer Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Oncology/Cancer Drugs in Blood Cancer
-
4.4.2 Market Size and Growth Rate of Oncology/Cancer Drugs in Breast Cancer
-
4.4.3 Market Size and Growth Rate of Oncology/Cancer Drugs in Gastrointestinal Cancer
-
4.4.4 Market Size and Growth Rate of Oncology/Cancer Drugs in Prostate Cancer
-
4.4.5 Market Size and Growth Rate of Oncology/Cancer Drugs in Respiratory/Lung Cancer
-
4.4.6 Market Size and Growth Rate of Oncology/Cancer Drugs in Other
5 Market Analysis by Regions
-
5.1 USA Oncology/Cancer Drugs Production Analysis by Regions
-
5.2 USA Oncology/Cancer Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Oncology/Cancer Drugs Landscape Analysis
-
6.1 West USA Oncology/Cancer Drugs Landscape Analysis by Major Types
-
6.2 West USA Oncology/Cancer Drugs Landscape Analysis by Major End-Users
7 South USA Oncology/Cancer Drugs Landscape Analysis
-
7.1 South USA Oncology/Cancer Drugs Landscape Analysis by Major Types
-
7.2 South USA Oncology/Cancer Drugs Landscape Analysis by Major End-Users
8 Middle West USA Oncology/Cancer Drugs Landscape Analysis
-
8.1 Middle West USA Oncology/Cancer Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Oncology/Cancer Drugs Landscape Analysis by Major End-Users
9 Northeast USA Oncology/Cancer Drugs Landscape Analysis
-
9.1 Northeast USA Oncology/Cancer Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Oncology/Cancer Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Sanofi
-
10.1.1 Sanofi Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Eli Lilly and Company
-
10.2.1 Eli Lilly and Company Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 HENGRUI
-
10.3.1 HENGRUI Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 GuiZhou YiBai
-
10.4.1 GuiZhou YiBai Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 LUYE
-
10.5.1 LUYE Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 HANSOH
-
10.6.1 HANSOH Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Roche
-
10.7.1 Roche Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 AstraZeneca
-
10.8.1 AstraZeneca Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Novartis
-
10.9.1 Novartis Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 QILU
-
10.10.1 QILU Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Lunan
-
10.11.1 Lunan Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Oncology/Cancer Drugs Market Size and Growth Rate of Antimetabolite from 2016 to 2027
-
Figure USA Oncology/Cancer Drugs Market Size and Growth Rate of Alkaloid Drugs from 2016 to 2027
-
Figure USA Oncology/Cancer Drugs Market Size and Growth Rate of Hormone from 2016 to 2027
-
Figure USA Oncology/Cancer Drugs Market Size and Growth Rate of Targeted Drug from 2016 to 2027
-
Figure USA Oncology/Cancer Drugs Market Size and Growth Rate of Platinum-based Drugs from 2016 to 2027
-
Figure USA Oncology/Cancer Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Oncology/Cancer Drugs Market Size and Growth Rate of Blood Cancer from 2016 to 2027
-
Figure USA Oncology/Cancer Drugs Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
Figure USA Oncology/Cancer Drugs Market Size and Growth Rate of Gastrointestinal Cancer from 2016 to 2027
-
Figure USA Oncology/Cancer Drugs Market Size and Growth Rate of Prostate Cancer from 2016 to 2027
-
Figure USA Oncology/Cancer Drugs Market Size and Growth Rate of Respiratory/Lung Cancer from 2016 to 2027
-
Figure USA Oncology/Cancer Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Oncology/Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Oncology/Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Oncology/Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Oncology/Cancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Oncology/Cancer Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Oncology/Cancer Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Oncology/Cancer Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Oncology/Cancer Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Antimetabolite
-
Figure Market Size and Growth Rate of Alkaloid Drugs
-
Figure Market Size and Growth Rate of Hormone
-
Figure Market Size and Growth Rate of Targeted Drug
-
Figure Market Size and Growth Rate of Platinum-based Drugs
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Oncology/Cancer Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Oncology/Cancer Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Blood Cancer
-
Figure Market Size and Growth Rate of Breast Cancer
-
Figure Market Size and Growth Rate of Gastrointestinal Cancer
-
Figure Market Size and Growth Rate of Prostate Cancer
-
Figure Market Size and Growth Rate of Respiratory/Lung Cancer
-
Figure Market Size and Growth Rate of Other
-
Table USA Oncology/Cancer Drugs Production by Regions
-
Table USA Oncology/Cancer Drugs Production Share by Regions
-
Figure USA Oncology/Cancer Drugs Production Share by Regions in 2016
-
Figure USA Oncology/Cancer Drugs Production Share by Regions in 2021
-
Figure USA Oncology/Cancer Drugs Production Share by Regions in 2027
-
Table USA Oncology/Cancer Drugs Consumption by Regions
-
Table USA Oncology/Cancer Drugs Consumption Share by Regions
-
Figure USA Oncology/Cancer Drugs Consumption Share by Regions in 2016
-
Figure USA Oncology/Cancer Drugs Consumption Share by Regions in 2021
-
Figure USA Oncology/Cancer Drugs Consumption Share by Regions in 2027
-
Table West USA Oncology/Cancer Drugs Consumption by Types from 2016 to 2027
-
Table West USA Oncology/Cancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Oncology/Cancer Drugs Consumption Share by Types in 2016
-
Figure West USA Oncology/Cancer Drugs Consumption Share by Types in 2021
-
Figure West USA Oncology/Cancer Drugs Consumption Share by Types in 2027
-
Table West USA Oncology/Cancer Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Oncology/Cancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Oncology/Cancer Drugs Consumption Share by End-Users in 2016
-
Figure West USA Oncology/Cancer Drugs Consumption Share by End-Users in 2021
-
Figure West USA Oncology/Cancer Drugs Consumption Share by End-Users in 2027
-
Table South USA Oncology/Cancer Drugs Consumption by Types from 2016 to 2027
-
Table South USA Oncology/Cancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Oncology/Cancer Drugs Consumption Share by Types in 2016
-
Figure South USA Oncology/Cancer Drugs Consumption Share by Types in 2021
-
Figure South USA Oncology/Cancer Drugs Consumption Share by Types in 2027
-
Table South USA Oncology/Cancer Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Oncology/Cancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Oncology/Cancer Drugs Consumption Share by End-Users in 2016
-
Figure South USA Oncology/Cancer Drugs Consumption Share by End-Users in 2021
-
Figure South USA Oncology/Cancer Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Oncology/Cancer Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Oncology/Cancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Oncology/Cancer Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Oncology/Cancer Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Oncology/Cancer Drugs Consumption Share by Types in 2027
-
Table Middle West USA Oncology/Cancer Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Oncology/Cancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Oncology/Cancer Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Oncology/Cancer Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Oncology/Cancer Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Oncology/Cancer Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Oncology/Cancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Oncology/Cancer Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Oncology/Cancer Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Oncology/Cancer Drugs Consumption Share by Types in 2027
-
Table Northeast USA Oncology/Cancer Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Oncology/Cancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Oncology/Cancer Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Oncology/Cancer Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Oncology/Cancer Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Eli Lilly and Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
-
Figure Revenue and Market Share Analysis of Eli Lilly and Company
-
Table Product and Service Introduction of Eli Lilly and Company
-
Table Company Profile and Development Status of HENGRUI
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of HENGRUI
-
Figure Sales and Growth Rate Analysis of HENGRUI
-
Figure Revenue and Market Share Analysis of HENGRUI
-
Table Product and Service Introduction of HENGRUI
-
Table Company Profile and Development Status of GuiZhou YiBai
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GuiZhou YiBai
-
Figure Sales and Growth Rate Analysis of GuiZhou YiBai
-
Figure Revenue and Market Share Analysis of GuiZhou YiBai
-
Table Product and Service Introduction of GuiZhou YiBai
-
Table Company Profile and Development Status of LUYE
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of LUYE
-
Figure Sales and Growth Rate Analysis of LUYE
-
Figure Revenue and Market Share Analysis of LUYE
-
Table Product and Service Introduction of LUYE
-
Table Company Profile and Development Status of HANSOH
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of HANSOH
-
Figure Sales and Growth Rate Analysis of HANSOH
-
Figure Revenue and Market Share Analysis of HANSOH
-
Table Product and Service Introduction of HANSOH
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of QILU
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of QILU
-
Figure Sales and Growth Rate Analysis of QILU
-
Figure Revenue and Market Share Analysis of QILU
-
Table Product and Service Introduction of QILU
-
Table Company Profile and Development Status of Lunan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lunan
-
Figure Sales and Growth Rate Analysis of Lunan
-
Figure Revenue and Market Share Analysis of Lunan
-
Table Product and Service Introduction of Lunan
-
